Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A micro opioid receptor gene polymorphism (A118G) and naltrexone treatment response in adherent Korean alcohol-dependent patients.

Psychopharmacology - 1 Jan 2009

Kim Sung-Gon, Kim Cheol-Min, Choi Sam-Wook, Jae Young-Myo, Lee Hae-Gook, Son Bong-Ki, Kim Jeong-Gee, Choi Young-Sung, Kim Han-Oh, Kim Seong-Yeon, Oslin David W

Abstract excerpt

RATIONALE: Previous studies have demonstrated an association between genetic polymorphisms of the mu opioid receptor gene (OPRM1) and response to naltrexone treatment. The Asp40 variant genotype previously shown to be associated with naltrexone treatment response is known to be relatively common...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alcoholism
Share to Cognitive Behavioral Therapy
Share to Korea

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Medication Adherence

Share to Naltrexone

Share to Narcotic Antagonists

Share to Receptors, Opioid, mu

Share to Recurrence

Source

Identifiers

PMID: 18795264
DOI: 10.1007/s00213-008-1330-5

Genes

OPRM1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-18795264-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A micro opioid receptor gene polymorphism (A118G) and naltrexone treatment response in adherent Korean alcohol-dependent patients.PMID 18795264Read ↗

Association of functional opioid receptor genotypes with alcohol dependence in Koreans.Semantic proximity Read ↗

An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study.Semantic proximity Read ↗

Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study.Semantic proximity Read ↗

Pharmacogenetics of naltrexone in asian americans: a randomized placebo-controlled laboratory study.Semantic proximity Read ↗

The μ-opioid receptor and treatment response to naltrexone.Semantic proximity Read ↗

The role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treatment: a critical review.Semantic proximity Read ↗

Pharmacogenetic Effects of Naltrexone in Individuals of East Asian Descent: Human Laboratory Findings from a Randomized Trial.Semantic proximity Read ↗

Opioid pharmacogenetics of alcohol addiction.Semantic proximity Read ↗

Effects of opioid receptor gene variation on targeted nalmefene treatment in heavy drinkers.Semantic proximity Read ↗

Human mu-opioid receptor variation and alcohol dependence.Semantic proximity Read ↗

Association of µ-opioid receptor (OPRM1) gene polymorphism with response to naltrexone in alcohol dependence: a systematic review and meta-analysis.Semantic proximity Read ↗

Influence of the OPRM1 A118G polymorphism on alcohol-induced euphoria, risk for alcoholism and the clinical efficacy of naltrexone.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.